Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...

The Delhi Police on February 15 arrested eight people in connection with a terror module linked to anti-national activities, according to Additional CP (Special Cell) Pramod Singh Kushwaha. Of the ...

Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

JS207, Junshi Biosciences’ independently developed recombinant humanized anti-PD-1/VEGF bispecific antibody, has demonstrated promising anti-tumor activity and a manageable safety profile in both ...

Leronlimab-mediated CCR5 blockade modulates T-Cell exhaustion pathways and PD-L1 Biology relevant to ICI responseDurable Clinical Observations ...

The trial of nine suspected members of a self-admitted antifa cell is restarting, following an abrupt mistrial declared last week, as they face federal terrorism-related charges stemming from their ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech ...

Subcutaneous (SC) amivantamab reduces administration from hours to minutes, with efficacy and safety consistent with intravenous (IV) amivantamab1,2,3,4,5 ...

At the centre of the plot is Shabir Ahmed Lone, an Indian-born, Bangladesh-based operative accused of orchestrating recruitment, propaganda and logistics for Lashkar inside India.

(PTx) announced findings from a post hoc analysis of the eNRGy trial (NCT02912949) evaluating treatment beyond progression with zenocutuzumab in patients with advanced neuregulin 1 fusion-positive ...

Shabir Ahmed Lone - the Indian-born Bangladesh-based alleged handler of a Lashkar-e-Taiba terrorist module busted in Delhi ...